Effect of vitamin D treatment on TSH level, in subclinical hypothyroidism & vitamin D deficient wome

Not Applicable

• Conditions: Subclinical hypothyroidism.; Iodine-deficiency-related (endemic) goitre, unspecified

• Registration Number: IRCT2016062813612N8
• Lead Sponsor: Vice Chancellor for Research of Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 25

Inclusion Criteria

Criteria for this study: women over 18 years old; patients with subclinical hypothyroidism with TSH higher than 4.5 mlu / L and less than 10 mlu / L; patients with vitamin D deficiency who are defined with 25 (OH) D3 less than 30 mlu / L.
Exclusion criteria: patients with systemic diseases (Kidney - lung - Haematic - Digestive); taking medicatiobs that affect on the metabolism of vitamin D; older than 65 years old or younger than 18 years old; being pregnant or plan to become pregnant; patient dissatisfaction to participate in the study.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Thyroid-stimulating hormone(TSH). Timepoint: Baseline and 3 months after treatment. Method of measurement: Test.;Vitamin D. Timepoint: Baseline and 3 months after treatment. Method of measurement: Test.

Secondary Outcome Measures

Name	Time	Method
Thyroid Function (FT4). Timepoint: Baseline and 3 months after treatment. Method of measurement: Test.;Thyroid peroxidase antibody. Timepoint: Baseline and 3 months after treatment. Method of measurement: Test.